Skip to main content
Marcelo Pasquini, MD, Oncology, Milwaukee, WI

MarceloCPasquiniMD

Oncology Milwaukee, WI

Hematologic Oncology

Assistant Professor, Medicine, Medical College of Wisconsin

Dr. Pasquini is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pasquini's full profile

Already have an account?

  • Office

    9200 W Wisconsin Ave
    # Froedter
    Milwaukee, WI 53226
    Phone+1 414-805-4100
    Fax+1 414-955-0231

Education & Training

  • Medical College of Wisconsin Affiliated Hospitals
    Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2004 - 2005
  • University of Utah Health
    University of Utah HealthFellowship, Hematology and Medical Oncology, 2001 - 2004
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
  • Other
    OtherClass of 1996

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2004 - 2025
  • UT State Medical License
    UT State Medical License 2001 - 2008
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Narrowing the Gap for Hematopoietic Stem Cell Transplantation in the East-Mediterranean/African Region: Comparison with Global HSCT Indications and Trends  
    Marcelo Pasquini, Daniel Weisdorf, Nature

Abstracts/Posters

  • Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)
    Marcelo C. Pasquini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Datab...
    Marcelo C. Pasquini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Tran...
    Marcelo C. Pasquini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Friday Scientific Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Center for International Blood & Marrow Transplant Research Celebrates 50 Years
    Center for International Blood & Marrow Transplant Research Celebrates 50 YearsApril 22nd, 2022
  • Out-of-Spec CAR-T Appears Safe, Effective for Younger Patients with ALL
    Out-of-Spec CAR-T Appears Safe, Effective for Younger Patients with ALLJanuary 31st, 2022
  • The IL-6 Antagonist Tocilizumab Is Associated with Worse Depression and Related Symptoms in the Medically Ill
    The IL-6 Antagonist Tocilizumab Is Associated with Worse Depression and Related Symptoms in the Medically IllJanuary 18th, 2021
  • Join now to see all

Professional Memberships